Women Commencing Anastrozole, Letrozole or Tamoxifen for Early Breast Cancer: The Impact of Comorbidity and Demographics on Initial Choice

Research output: Contribution to journal › Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{f3828017348540a982a95710501ecd7d,

title = "Women Commencing Anastrozole, Letrozole or Tamoxifen for Early Breast Cancer: The Impact of Comorbidity and Demographics on Initial Choice",

author = "Anna Kemp and David Preen and Christobel Saunders and F. Boyle and Mahesh Bulsara and D'Arcy Holman and Eva Malacova and E.E. Roughead",

year = "2014",

doi = "10.1371/journal.pone.0084835",

language = "English",

volume = "9",

pages = "8pp",

journal = "PLoS One",

issn = "1932-6203",

publisher = "Public Library of Science (PLoS)",

number = "1",

}

TY - JOUR

T1 - Women Commencing Anastrozole, Letrozole or Tamoxifen for Early Breast Cancer: The Impact of Comorbidity and Demographics on Initial Choice

AU - Kemp, Anna

AU - Preen, David

AU - Saunders, Christobel

AU - Boyle, F.

AU - Bulsara, Mahesh

AU - Holman, D'Arcy

AU - Malacova, Eva

AU - Roughead, E.E.

PY - 2014

Y1 - 2014

U2 - 10.1371/journal.pone.0084835

DO - 10.1371/journal.pone.0084835

M3 - Article

C2 - 24392158

SN - 1932-6203

VL - 9

SP - 8pp

JO - PLoS One

JF - PLoS One

IS - 1

ER -